Three Questions

Three Questions: David Izard, Chiltern

Tuesday, May 30, 2017

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Sony Salzman spoke with David Izard, senior director, Clinical Data Standards at Chiltern. He co-authored the white paper “The Case For Embracing The FDA’s Endorsed Data Standards.”

[Read More]

Three Questions: Norman Goldfarb, MAGI

Monday, May 15, 2017

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Suz Redfearn spoke with Norman Goldfarb, chairman of Model Agreements & Guidelines International (MAGI), an organization that has spent a decade promoting the standardization of clinical trial agreements (CTAs) and contract templates that both sites and CROs or sponsors can use to speed study startup. Goldfarb is also editor of The Journal of Clinical Research Best Practices, and managing director of First Clinical Research. In April, the Association of Clinical Research Professionals gave Goldfarb their award for innovation for the MAGI CTA initiative.

[Read More]

Three Questions: Deborah Miller, patient recruitment expert

Monday, May 1, 2017

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, Lisa Chontos spoke with Deborah Miller, who has also authored the book, Winning At Patient Recruitment: Achieving Enrollment Goals Through Outbound Telephone Screening.

[Read More]

Three Questions: Liz Christianson, PFS Clinical

Monday, April 17, 2017

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Barbara M. Bolten spoke with Liz Christianson, senior clinical research analyst at PFS Clinical. Liz specializes in budget development/negotiation, coverage analysis development and clinical trial financial management.

[Read More]

Three Questions: Matt Kibby, BBK Worldwide

Monday, March 20, 2017

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Sony Salzman spoke with Matt Kibby, president of BBK Worldwide. Matt leads BBK’s technology group, which develops and integrates the company’s patient recruitment data systems to optimize studies for sponsors and CROs globally.

[Read More]

Three Questions: Dr. Martin Gibson, NorthWest EHealth

Monday, March 6, 2017

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Suz Redfearn spoke with Dr. Martin Gibson, chief executive of the U.K.’s NorthWest EHealth, which develops links between academia and the U.K.’s National Health System in health informatics and the use of electronic patient records to support research. Dr. Gibson helped develop the Salford Lung Studies, two recent GSK-sponsored trials that substituted EHR for regular patient visits.

[Read More]

Three Questions: Dawn M. Furey, Merck & Co.

Tuesday, February 21, 2017

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Barbara M. Bolten spoke with Dawn M. Furey, executive director, head of Global Operations, Global Clinical Trial Operations, Merck & Co. Furey leads the global alignment of strategies for implementation of clinical trial operations with a focus on trial feasibility and allocation, trial site documentation, enrollment/retention planning and support of project delivery. She also led the implementation of a cloud-based electronic trial master file solution, Veeva Vault eTMF.

[Read More]

Three Questions: Jeff Pohlig, Compass Research

Monday, February 6, 2017

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Karyn Korieth spoke with Jeff Pohlig, vice president, U.S. Operations for Compass Research, which is part of the Bioclinica Research Network. Compass Research, which has three locations in Central Florida, was a finalist for the Society for Clinical Research Sites’ 2016 Site Patient Recruitment Innovation Award (SPRIA), which recognizes research sites that have developed and implemented innovative patient recruitment programs.

[Read More]

Three Questions: Mohammad A. Millwala, DM Clinical Research

Monday, January 23, 2017

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Karyn Korieth spoke with Mohammad A. Millwala, CEO of DM Clinical Research, a network of investigative sites based out of Tomball, Texas. DM Clinical Research was a finalist for the Society for Clinical Research Sites’ 2016 Site Patient Recruitment Innovation Award (SPRIA), which recognizes research sites that have developed and implemented innovative patient recruitment programs.

[Read More]